GlaxoSmithKline’s antiseizure drug, Lamictal® (lamotrigine), was approved for a new epilepsy indication—one of the most serious forms of epilepsy, primary generalized tonic-clonic (PGTC) seizures.
A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...
On September 16, SK Biopharmaceuticals announced that it has obtained positive top-line results from a Phase 3 clinical trial evaluating cenobamate (U.S. brand name XCOPRI®), its innovative ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant ...
The Key Tonic clonic Seizure Companiesin theamrket include - Emory University, Pfizer, GlaxoSmithKline, Eisai Inc., Xenon Pharmaceuticals, UCB Pharma, Johnson ...
Do not start sodium valproate for the first time in people (male or female) younger than 55 years, unless 2 specialists independently agree and document that there is no other effective and tolerated ...
November is Epilepsy Awareness Month. Many people may already be aware of the condition from its prevalence in medical dramas, but that portrayal is often exaggerated and does not fully encapsulate ...
Lacosamide 100mg, 150mg, 200mg; ext-rel caps. The precise mechanism by which Motpoly XR exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies ...
LONDON, June 05, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced completion of the CORE-VNS study, evaluating comprehensive outcomes of ...
Jon Kyle Andersen refreshes our knowledge on common medical emergencies. You have full access to this article via your institution. A severe, life-threatening, generalised or systemic hypersensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results